Poplin EA - Search Results

1

Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060.

Poplin EA, Jacobson J, Herskovic A, Panella TJ, Valdivieso M, Hutchins LF, Macdonald JS. Poplin EA, et al. Cancer. 1996 Nov 1;78(9):1851-6. Cancer. 1996. PMID: 8909302 Clinical Trial.

2

Chemoradiotherapy of esophageal carcinoma.

Poplin EA, Khanuja PS, Kraut MJ, Herskovic AM, Lattin PB, Cummings G, Gaspar LE, Kinzie JL, Steiger Z, Vaitkevicius VK. Poplin EA, et al. Cancer. 1994 Aug 15;74(4):1217-24. doi: 10.1002/1097-0142(19940815)74:4<1217::aid-cncr2820740407>3.0.co;2-o. Cancer. 1994. PMID: 8055441

3

Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934).

LoRusso P, Foster BJ, Poplin E, McCormick J, Kraut M, Flaherty L, Heilbrun LK, Valdivieso M, Baker L. LoRusso P, et al. Clin Cancer Res. 1995 Dec;1(12):1487-93. Clin Cancer Res. 1995. PMID: 9815948 Clinical Trial.

4

Amonafide treatment of refractory esophageal cancer. A Southwest Oncology Group study.

Poplin E, Fleming T, MacDonald JS, Eisenberg P, Fisher RI, Conrad ME. Poplin E, et al. Invest New Drugs. 1993 Feb;11(1):47-51. doi: 10.1007/BF00873910. Invest New Drugs. 1993. PMID: 8349435 Clinical Trial.

5

Hepatoma/merbarone. A Southwest Oncology Group study.

Poplin EA, Tangen CM, Harvey WH, Macdonald JS. Poplin EA, et al. Invest New Drugs. 1994;12(4):337-40. doi: 10.1007/BF00873051. Invest New Drugs. 1994. PMID: 7775137 Clinical Trial.

6

Adjuvant continuous infusion 5-FU, whole-abdominal radiation, and tumor bed boost in high-risk stage III colon carcinoma: a Southwest Oncology Group Pilot study.

Fabian C, Giri S, Estes N, Tangen CM, Poplin E, Vogel S, Goodwin W, Rivkin S, Fleming TR, Macdonald JS. Fabian C, et al. Int J Radiat Oncol Biol Phys. 1995 May 15;32(2):457-64. doi: 10.1016/0360-3016(94)00600-P. Int J Radiat Oncol Biol Phys. 1995. PMID: 7751186

7

Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.

Poplin EA, Benedetti JK, Estes NC, Haller DG, Mayer RJ, Goldberg RM, Weiss GR, Rivkin SE, Macdonald JS. Poplin EA, et al. J Clin Oncol. 2005 Mar 20;23(9):1819-25. doi: 10.1200/JCO.2005.04.169. J Clin Oncol. 2005. PMID: 15774775 Clinical Trial.

8

Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.

Poplin EA, Corbett T, Flaherty L, Tarasoff P, Redman BG, Valdivieso M, Baker L. Poplin EA, et al. Invest New Drugs. 1992 Aug;10(3):165-70. doi: 10.1007/BF00877241. Invest New Drugs. 1992. PMID: 1428726 Clinical Trial.

9

ZD9331 in combination with topotecan: phase I and II experience.

Benson A 3rd, Poplin E, Vergote I. Benson A 3rd, et al. Anticancer Drugs. 2003 May;14 Suppl 1:S21-7. doi: 10.1097/00001813-200305001-00004. Anticancer Drugs. 2003. PMID: 14567437 Review.

10

Phase I study of monoclonal antibody-ricin A chain immunoconjugate Xomazyme-791 in patients with metastatic colon cancer.

LoRusso PM, Lomen PL, Redman BG, Poplin E, Bander JJ, Valdivieso M. LoRusso PM, et al. Am J Clin Oncol. 1995 Aug;18(4):307-12. doi: 10.1097/00000421-199508000-00008. Am J Clin Oncol. 1995. PMID: 7625372 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters